MARAGANORE JOHN — SEC Form 4 filings
SEC reporting owner CIK 1180432. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-06.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-07 to 2026-07-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Hemab Therapeutics Holdings, Inc. (COAG) | Director | 1 | — | — | 5 |
| Beam Therapeutics Inc. (BEAM) | Director | 3 | — | — | 3 |
| Kymera Therapeutics, Inc. (KYMR) | Director | 3 | — | — | 3 |
| TAKEDA PHARMACEUTICAL CO LTD (TAK) | Director | 1 | — | — | 3 |
| Rapport Therapeutics, Inc. (RAPP) | Director | 2 | — | — | 2 |
Form 4 filings — MARAGANORE JOHN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | TAKEDA PHARMACEUTICAL CO LTD (TAK) | Grant/award (A): 3,800 @ $0 · Disposition to issuer (D): 1,152 (derivative) @ $4,931.20 · Grant/award (A): 1,319 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-06-10 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 15,200 (derivative) @ $0 | EDGAR |
| 2026-06-05 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 19,676 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Hemab Therapeutics Holdings, Inc. (COAG) | Conversion (C): 17,974 · Conversion (C): 17,974 · Grant/award (A): 107,338 (derivative) @ $0 · Conversion (C): 817 (derivative) @ $0 · Conversion (C): 817 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 21,850 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 33,662 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Beam Therapeutics Inc. (BEAM) | Grant/award (A): 23,114 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1180432 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →